Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 69, Issue 2
Volume 69, Issue 2
15 July 2019
ISSN 1058-4838
EISSN 1537-6591

Volume 69, Issue 2, 15 July 2019

NEWS

Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages i–ii, https://doi.org/10.1093/cid/ciz268

IN THE LITERATURE

Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages iii–iv, https://doi.org/10.1093/cid/ciz357

ARTICLES AND COMMENTARIES

Bradley Ackerson and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 197–203, https://doi.org/10.1093/cid/ciy991

Older adults hospitalized with respiratory syncytial virus (RSV) or influenza were compared. RSV infection was associated with longer hospitalization and greater odds of pneumonia, intensive care unit admission, and 1-year mortality. Recognition of adult RSV disease is needed to facilitate future vaccination and treatment.

Angela R Branche
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 204–206, https://doi.org/10.1093/cid/ciy880
Anne Derache and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 207–214, https://doi.org/10.1093/cid/ciy881

We documented a high prevalence of pretreatment drug resistance (PDR) among participants enrolled in trial clinics in rural KwaZulu-Natal. Dual-class PDR to a first-line tenofovir/emtricitabine/efavirenz regimen was associated with poorer virological suppression. However, there was no impact of nonnucleoside reverse transcriptase inhibitor PDR alone.

Robert W Shafer and Lisa M Frenkel
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 215–217, https://doi.org/10.1093/cid/ciy895
Sarah A Mbayei and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 218–226, https://doi.org/10.1093/cid/ciy889

Infants aged <2 months are at greatest risk for pertussis-related hospitalization, and severe pertussis infections occur in persons of all ages. Pertussis vaccination remains the most important tool for the prevention of severe infection.

Violeta Balinskaite and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 227–232, https://doi.org/10.1093/cid/ciy902

This study aimed to evaluate the association between antimicrobial stewardship with financial incentive and a reduction of antibiotic prescribing. This study shows that pay-for-performance can significantly reduce antibiotic use: specifically, the use of broad-spectrum antibiotics.

Violeta Balinskaite and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 233–242, https://doi.org/10.1093/cid/ciy904

This study aimed to evaluate possible unintended clinical outcomes related to an antimicrobial program with financial incentive. This study shows that overall there was no significant association between the intervention and unintended clinical consequences in primary and secondary care.

Ira Praharaj and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 243–250, https://doi.org/10.1093/cid/ciy896

Quantitative molecular testing of stool samples for enteropathogens from diarrheal episodes from a phase 3 rotavirus vaccine efficacy trial revealed high coinfection rates, and there was a 11.3% improvement in vaccine efficacy estimates after accounting for these coinfections.

Dinesh Mondal and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 251–258, https://doi.org/10.1093/cid/ciy891

We report xenodiagnosis results for 47 post-kala-azar dermal leishmaniasis (PKDL) and 15 visceral leishmaniasis (VL) patients. Skin parasite load was strongly associated with positive xenodiagnosis. Compared to VL (66.7%), nodular PKDL was more likely (86%) and macular PKDL less likely (35%) to result in positive xenodiagnosis.

Lilian Abbo and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 259–265, https://doi.org/10.1093/cid/ciy903

A vancomycin-resistant enterococci outbreak occurred in a large organ transplant center and remained undetected due to limitations of conventional testing methods. Whole genome sequencing revealed a subpopulation of organisms harboring the G2576C mutation affecting 23S ribosomal RNA and conferring resistance to linezolid.

Audrey N Schuetz
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 266–267, https://doi.org/10.1093/cid/ciy1023
S Graspeuntner and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 268–277, https://doi.org/10.1093/cid/ciy882

In a large cohort of preterm neonates, a Bacilli-mediated intestinal dysbiosis with a lack of anaerobic bacteria and an accumulation of fermentation products preceded the development of sepsis. These data offer potential biomarkers and therapeutic targets for prevention of sepsis.

Julia Mwesigwa and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 278–286, https://doi.org/10.1093/cid/ciy870

Annual mass drug administration (MDA) with dihydroartemisinin-piperaquine over 2 years reduced the incidence of malaria infection and clinical disease, but was not sustained in eastern Gambia. Multiple MDA rounds over large areas may result in larger and sustained transmission reductions.

Jennifer L Guler and Philip J Rosenthal
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 287–289, https://doi.org/10.1093/cid/ciy871
Jan A Roth and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 290–294, https://doi.org/10.1093/cid/ciy879

Frequent door openings during cardiac surgery were independently associated with an increased risk for surgical site infection (SSI). This finding warrants further study to establish a potentially causal relationship between door openings and the occurrence of SSIs.

Maia Lesosky and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 295–305, https://doi.org/10.1093/cid/ciy823

In prevalent tuberculosis (TB), incident TB, and control samples, we evaluated 13 plasma biomarkers to identify individuals infected with human immunodeficiency virus–1 who were susceptible to active TB: biomarkers differentiated prevalent TB from control samples, but not incident TB.

Emily P Hyle and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 306–315, https://doi.org/10.1093/cid/ciy861

A pretravel measles-mumps-rubella (MMR) vaccination could offer good value or be cost saving for travelers with a higher risk of measles exposure, especially if they are previously unvaccinated or returning to a US community with heterogeneous MMR coverage.

Daisuke Shigemi and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 316–322, https://doi.org/10.1093/cid/ciy862

Using a national inpatient database, 27841 patients diagnosed with pelvic inflammatory disease were identified. Initial treatment for Chlamydia trachomatis was significantly associated with less surgical intervention and lower mortality rate by propensity score–matched analysis.

Andrew H Talal and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 323–331, https://doi.org/10.1093/cid/ciy899

Telemedicine can virtually integrate treatment for hepatitis C virus (HCV) into the opioid substitution therapy program with virological outcomes equivalent to those in clinical trials. Analysis of psychosocial and demographic variables can also identify patients willing to pursue HCV therapy.

Damien Contou and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 332–340, https://doi.org/10.1093/cid/ciy901

Long-term health-related quality of life does not significantly differ between patients surviving purpura fulminans (PF) and those surviving septic shock unrelated to PF. PF survivors who required limb amputation have an impaired long-term physical health-related quality of life but a preserved mental health.

BRIEF REPORTS

Rafael Harpaz and Jessica W Leung
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 341–344, https://doi.org/10.1093/cid/ciy953
Rafael Harpaz and Jessica W Leung
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 345–347, https://doi.org/10.1093/cid/ciy954
Nicole L Sullivan and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 348–351, https://doi.org/10.1093/cid/ciy984

VIEWPOINTS

Matthew Zahn and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 352–356, https://doi.org/10.1093/cid/ciy888

Infectious diseases (ID) physicians perform valuable roles protecting public health, but many of their activities are poorly compensated. Compensation policy changes are needed to allow the ID field to continue to attract the best and brightest medical students and residents.

REVIEW ARTICLE

Jennifer L Cannon and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 357–365, https://doi.org/10.1093/cid/ciy985

Birth cohort studies show that noroviruses are high-incidence pathogens associated with diarrhea among young children, particularly those aged ≥6 months in low/middle-income countries. Evidence for immunity and genetically determined risk factors are provided and important limitations and considerations are discussed.

INVITED ARTICLE

CLINICAL PRACTICE

Poonam Beniwal-Patel and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 366–372, https://doi.org/10.1093/cid/ciz061

The detection of Clostridium difficile in inflammatory bowel disease (IBD) patients is a common occurrence. Here, we review the epidemiology, clinical presentation, risk factors, diagnosis, treatment, and outcomes of IBD patients with positive C. difficile tests.

PHOTO QUIZ

André M S Silva and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 373–375, https://doi.org/10.1093/cid/ciy755

CORRESPONDENCE

David Nalin
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Page 376, https://doi.org/10.1093/cid/ciy1014
David Wimmersberger and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 376–377, https://doi.org/10.1093/cid/ciy1015
Govindakarnavar Arunkumar and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 377–378, https://doi.org/10.1093/cid/ciy1092
Devendra T Mourya and others
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 378–379, https://doi.org/10.1093/cid/ciy1093
Narayan Paudyal and Min Yue
Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Pages 379–380, https://doi.org/10.1093/cid/ciz007

COVER

Clinical Infectious Diseases, Volume 69, Issue 2, 15 July 2019, Page NP, https://doi.org/10.1093/cid/ciz513
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close